Novel Technologies for Alzheimer’s and Dementia Treatments

The Molecular Biology Institute at UCLA
presents a special virtual event

Novel Technologies for Alzheimer’s and Dementia Treatments

an illuminating conversation featuring

David Eisenberg, D.Phil.
The P.D. Boyer Professor of Biochemistry and Molecular Biology,
Molecular Biology Institute
Investigator, Howard Hughes Medical Institute

Tamir Gonen, Ph.D.
Professor, Biological Chemistry and Physiology
Investigator, Howard Hughes Medical Institute
Director, MicroED Imaging Center
Member, Molecular Biology Institute

Jose Alfonso Rodriguez, Ph.D.
Assistant Professor, Chemistry and Biochemistry
Member, Molecular Biology Institute

with Q&A moderated by

Hilary Coller, Ph.D.
Interim Director, Molecular Biology Institute
Professor, Molecular, Cell and Development Biology
Professor, Biological Chemistry

Join us to hear about promising new therapies for Alzheimer’s disease and dementia being developed thanks to collaborations among research teams at the Molecular Biology Institute at UCLA. The Institute is providing researchers with a unique platform to develop methods to define the structure of proteins and then apply these methods to create new therapies.

As a land grant institution, the UCLA College of Letters and Science acknowledges the
Gabrielino/Tongva
peoples as the traditional land caretakers of Tovaangar (Los Angeles basin, So. Channel Islands).